iCIDM · Publication Passport
CPD-1622
Explorer · Data Hub
Current population · 2,231

Use of Infliximab to Treat Paradoxical Tuberculous Meningitis Reactions.

Marais BJ, Cheong E, Fernando S, Daniel S, Watts MR, Berglund LJ, Barry SE, K...

← ExplorerSource ↗

Publication identity

Publication IDCPD-1622
Year2020
PMID33542942
DOI10.1093/ofid/ofaa604. eCollection 2021 Jan
JournalOpen Forum Infect Dis
AuthorsMarais BJ, Cheong E, Fernando S, Daniel S, Watts MR, Berglund LJ, Barry SE, K...
First authorMarais BJ
Senior authorStapledon RA

Scientific classification

Research themeTuberculosis / mycobacteria
Pathogen groupNot specified / mixed
Technology / methodNot specified / mixed
Object stateOBSERVED

Provenance & boundary

Generated Passport: this is a derived view of the canonical publication object. Missing or unsupported information remains unfilled; no scientific interpretation or current-staff status is manufactured.
PopulationCIDM Publications · 2,231
Source statussource-derived / affiliation verification required
Investigator sourceMatthew Watts,
Canonical source URLhttps://pubmed.ncbi.nlm.nih.gov/33542942/

Author / Colleague Reality Return

Return corrections about identity, authorship, paper-specific CIDM/CIDM-PH affiliation, metadata, source/provenance, figure/table linkage, evidence boundary, or links.

Feedback → source check → evidence status → warranted correction → versioned update.

Open feedback route →